News and Updates

City of Hope launches a cutting-edge clinical trial to map how tumors evolve, aiming to overcome immunotherapy resistance and improve cancer patient outcomes.

New clinical trials for CAR T-cell therapy offer hope for T-cell lymphoma patients. Learn how precision gene-editing is transforming blood cancer treatment.

Confused by Long COVID study data? Learn how to evaluate clinical trials, understand primary endpoints, and spot reliable research for PASC treatments.

New research suggests GLP-1 agonists may help reduce addiction-related hospitalizations, but findings show the benefits disappear once patients stop use.

Essential recall notice: Steerable sheaths used in PFA procedures are being pulled due to safety risks. Read the latest clinical update for providers.

Recent FDA data reveals a surge in Q2 pharmaceutical and medical device recalls linked to packaging failures and labeling errors. Learn the critical impact.

Kolon TissueGene’s Invossa-K fails Phase III trial for knee osteoarthritis. Learn how this clinical setback impacts the future of gene therapy treatments.

A groundbreaking clinical trial reveals CAR T-cell therapy shows promise for treating AL amyloidosis by targeting the root cause of protein buildup.

Health Canada has approved a Phase II/III clinical trial for Thykamine™ to treat pediatric atopic dermatitis in patients aged 3 months to 17 years.

Explore the latest clinical data on systemic JAK inhibitors for vitiligo. Discover how this emerging treatment works, its efficacy, and vital safety protocols.